Healthcare provider profile · identity verified

Ryan Christopher Tighe, D.O.

Family Practice · OAK ISLAND, NC · NPI 1164866588

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	701	196
Atorvastatin Calcium	Atorvastatin Calcium	541	143
Levothyroxine Sodium	Levothyroxine Sodium	419	96
Amlodipine Besylate	Amlodipine Besylate	341	94
Lisinopril	Lisinopril	291	82
Losartan Potassium	Losartan Potassium	258	63
Ezetimibe	Ezetimibe	254	69
Pantoprazole Sodium	Pantoprazole Sodium	248	80
Fluoxetine Hcl	Fluoxetine Hcl	217	57
Metoprolol Succinate	Metoprolol Succinate	212	51
Hydrochlorothiazide	Hydrochlorothiazide	184	48
Omeprazole	Omeprazole	183	49
Metformin Hcl Er	Metformin Hcl	161	48
Metformin Hcl	Metformin Hcl	151	45
Valsartan	Valsartan	151	41
Zolpidem Tartrate	Zolpidem Tartrate	151	34
Gabapentin	Gabapentin	145	35
Allopurinol	Allopurinol	135	34
Ozempic	Semaglutide	133	37
Alprazolam	Alprazolam	125	30
Tamsulosin Hcl	Tamsulosin Hcl	124	40
Bupropion Xl	Bupropion Hcl	122	29
Sertraline Hcl	Sertraline Hcl	119	32
Pravastatin Sodium	Pravastatin Sodium	117	31
Furosemide	Furosemide	115	30
Albuterol Sulfate Hfa	Albuterol Sulfate	114	32
Temazepam	Temazepam	114	13
Simvastatin	Simvastatin	113	27
Trazodone Hcl	Trazodone Hcl	110	31
Potassium Chloride	Potassium Chloride	109	32
Eliquis	Apixaban	105	19
Fluticasone Propionate	Fluticasone Propionate	99	36
Prednisone	Prednisone	96	61
Glimepiride	Glimepiride	93	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	90	32
Montelukast Sodium	Montelukast Sodium	89	26
Lovastatin	Lovastatin	82	24
Clonazepam	Clonazepam	77	16
Tramadol Hcl	Tramadol Hcl	76	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	75	11
Meloxicam	Meloxicam	73	25
Mounjaro	Tirzepatide	72	15
Carvedilol	Carvedilol	70	16
Escitalopram Oxalate	Escitalopram Oxalate	68	20
Doxepin Hcl	Doxepin Hcl	65	17
Tizanidine Hcl	Tizanidine Hcl	65	31
Amitriptyline Hcl	Amitriptyline Hcl	62	19
Diclofenac Sodium	Diclofenac Sodium	62	20
Lorazepam	Lorazepam	61	15
Ipratropium Bromide	Ipratropium Bromide	59	17
Duloxetine Hcl	Duloxetine Hcl	58	17
Quetiapine Fumarate	Quetiapine Fumarate	58	11
Atenolol	Atenolol	57	15
Pioglitazone Hcl	Pioglitazone Hcl	56	17
Venlafaxine Hcl Er	Venlafaxine Hcl	56	16
Synthroid	Levothyroxine Sodium	55	15
Clopidogrel	Clopidogrel Bisulfate	54	15
Metoprolol Tartrate	Metoprolol Tartrate	51	14
Esomeprazole Magnesium	Esomeprazole Magnesium	48	suppressed
Jardiance	Empagliflozin	48	14
Finasteride	Finasteride	45	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	12
Cephalexin	Cephalexin	43	33
Triamcinolone Acetonide	Triamcinolone Acetonide	43	27
Irbesartan	Irbesartan	40	suppressed
Valacyclovir	Valacyclovir Hcl	39	21
Alendronate Sodium	Alendronate Sodium	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	12
Eszopiclone	Eszopiclone	36	suppressed
Linzess	Linaclotide	36	suppressed
Topiramate	Topiramate	36	suppressed
Diazepam	Diazepam	35	suppressed
Famotidine	Famotidine	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Azithromycin	Azithromycin	34	32
Buspirone Hcl	Buspirone Hcl	34	suppressed
Estradiol	Estradiol	34	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Aripiprazole	Aripiprazole	32	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	31	31
Celecoxib	Celecoxib	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Naproxen	Naproxen	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	21
Spironolactone	Spironolactone	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Acyclovir	Acyclovir	24	suppressed
Nebivolol Hcl	Nebivolol Hcl	24	suppressed
Nystatin	Nystatin	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Nadolol	Nadolol	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Glipizide	Glipizide	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	16
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	20	suppressed
Ondansetron Odt	Ondansetron	19	12
Prazosin Hcl	Prazosin Hcl	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Fluconazole	Fluconazole	15	11
Lamotrigine	Lamotrigine	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Primidone	Primidone	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Colchicine	Colchicine	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Teriparatide	Teriparatide	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error